BridgeBio Pharma LLC Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BridgeBio Pharma LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BridgeBio Pharma LLC. BridgeBio Pharma LLC is 10% Owner in Eidos Therapeutics, Inc. ($EIDX) and 10% Owner in BridgeBio Pharma, Inc. ($BBIO).
Latest Insider Trading Transactions of BridgeBio Pharma LLC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 26 2021 | BBIO | BridgeBio Pharma, ... | BridgeBio Pharma, Inc. | 10% Owner | Buy | P | 0.00 | 14,428,836 | 0 | 1,000 | -14,427,836 to 1,000 (-100.01 %) |
| Jan 26 2021 | EIDX | Eidos Therapeutics ... | BridgeBio Pharma, Inc. | 10% Owner | Buy | P | 0.00 | 14,428,836 | 0 | 1,000 | -14,427,836 to 1,000 (-100.01 %) |
| Jul 08 2019 | BBIO | BridgeBio Pharma, ... | BridgeBio Pharma, Inc. | 10% Owner | Buy | P | 29.90 | 882,353 | 26,382,796 | 24,575,501 | 23.7 M to 24.6 M (+3.72 %) |
| Jul 08 2019 | BBIO | BridgeBio Pharma, ... | BridgeBio Pharma, Inc. | 10% Owner | Buy | P | 29.90 | 882,353 | 26,382,796 | 24,575,501 | 23.7 M to 24.6 M (+3.72 %) |
| Jul 08 2019 | EIDX | Eidos Therapeutics ... | BridgeBio Pharma, Inc. | 10% Owner | Buy | P | 29.90 | 882,353 | 26,382,796 | 24,575,501 | 23.7 M to 24.6 M (+3.72 %) |
| Jul 08 2019 | EIDX | Eidos Therapeutics ... | BridgeBio Pharma, Inc. | 10% Owner | Buy | P | 29.90 | 882,353 | 26,382,796 | 24,575,501 | 23.7 M to 24.6 M (+3.72 %) |
| May 29 2019 | EIDX | Eidos Therapeutics ... | BridgeBio Pharma, Inc. | 10% Owner | Buy | P | 25.93 | 1,103,848 | 28,622,779 | 23,693,148 | 22.6 M to 23.7 M (+4.89 %) |
| Dec 12 2018 | EIDX | Eidos Therapeutics ... | BridgeBio Pharma LLC | 10% Owner | Buy | S | 13.96 | 2,664 | 37,189 | 22,589,300 | 22.6 M to 22.6 M (+0.01 %) |
| Dec 12 2018 | EIDX | Eidos Therapeutics ... | BridgeBio Pharma LLC | 10% Owner | Buy | S | 13.29 | 37,989 | 504,874 | 22,586,636 | 22.5 M to 22.6 M (+0.17 %) |
| Dec 10 2018 | EIDX | Eidos Therapeutics ... | BridgeBio Pharma LLC | 10% Owner | Buy | S | 14.36 | 4,860 | 69,790 | 22,548,647 | 22.5 M to 22.5 M (+0.02 %) |
| Dec 10 2018 | EIDX | Eidos Therapeutics ... | BridgeBio Pharma LLC | 10% Owner | Buy | S | 13.94 | 36,314 | 506,217 | 22,543,787 | 22.5 M to 22.5 M (+0.16 %) |
| Dec 10 2018 | EIDX | Eidos Therapeutics ... | BridgeBio Pharma LLC | 10% Owner | Buy | S | 13.34 | 38,970 | 519,860 | 22,507,473 | 22.5 M to 22.5 M (+0.17 %) |
| Dec 06 2018 | EIDX | Eidos Therapeutics ... | BridgeBio Pharma LLC | 10% Owner | Buy | P | 14.01 | 1,103,848 | 15,464,910 | 22,468,503 | 21.4 M to 22.5 M (+5.17 %) |
| Dec 06 2018 | EIDX | Eidos Therapeutics ... | BridgeBio Pharma LLC | 10% Owner | Buy | P | 15.50 | 1,750,000 | 27,125,000 | 21,364,655 | 19.6 M to 21.4 M (+8.92 %) |
| Jun 26 2018 | EIDX | Eidos Therapeutics ... | BridgeBio Pharma LLC | 10% Owner | Option Exercise | C | 0.00 | 12,832,123 | 0 | 0 | |
| Jun 26 2018 | EIDX | Eidos Therapeutics ... | BridgeBio Pharma LLC | 10% Owner | Option Exercise | C | 0.00 | 2,909,029 | 0 | 0 | |
| Jun 26 2018 | EIDX | Eidos Therapeutics ... | BridgeBio Pharma LLC | 10% Owner | Option Exercise | X | 0.00 | 332,262 | 0 | 2,909,029 | |
| Jun 26 2018 | EIDX | Eidos Therapeutics ... | BridgeBio Pharma LLC | 10% Owner | Option Exercise | X | 10.83 | 332,262 | 3,599,992 | 0 | |
| Jun 26 2018 | EIDX | Eidos Therapeutics ... | BridgeBio Pharma LLC | 10% Owner | Buy | P | 17.00 | 1,000,000 | 17,000,000 | 19,614,655 | 18.6 M to 19.6 M (+5.37 %) |
| Jun 26 2018 | EIDX | Eidos Therapeutics ... | BridgeBio Pharma LLC | 10% Owner | Payment of Exercise | F | 17.00 | 211,762 | 3,599,954 | 18,614,655 | 18.8 M to 18.6 M (-1.12 %) |
| Jun 26 2018 | EIDX | Eidos Therapeutics ... | BridgeBio Pharma LLC | 10% Owner | Buy | C | 0.00 | 18,826,417 | 0 | 18,826,417 | 0 to 18.8 M |
Page: 1